Last 48 quarters of trend data · Real Estate · REIT - Healthcare Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
National Health Investors, Inc.'s quarterly P/E stands at 24.7x, down 1.2% year-over-year. EV/EBITDA has compressed 24.6% YoY to 12.7x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 24.85 | 24.65 | 23.87 | 28.80 | 22.19 | 24.95 | 18.24 | 32.33 | 20.90 | 22.12 | 18.87 | 18.88 | 14.24 |
| — | -1.2% | +30.9% | -10.9% | +6.1% | +12.8% | -3.3% | +71.2% | +46.8% | -69.1% | -93.8% | +4.2% | -76.5% | |
| P/S Ratio | 9.61 | 8.47 | 8.43 | 10.53 | 9.05 | 9.49 | 9.18 | 11.14 | 8.68 | 8.37 | 7.62 | 6.95 | 7.30 |
| — | -10.7% | -8.1% | -5.5% | +4.3% | +13.4% | +20.4% | +60.2% | +18.9% | +23.2% | -4.9% | -15.4% | -36.9% | |
| P/B Ratio | 2.29 | 2.58 | 2.33 | 2.53 | 2.19 | 2.35 | 2.27 | 2.96 | 2.34 | 2.15 | 1.90 | 1.74 | 1.76 |
| — | +9.9% | +2.7% | -14.8% | -6.1% | +9.0% | +19.5% | +70.4% | +32.5% | +23.9% | +8.3% | -8.0% | -10.1% | |
| P/FCF | 16.52 | 19.42 | 15.16 | 16.44 | 13.98 | 18.95 | 15.27 | 21.03 | 12.67 | 17.63 | 11.64 | 11.46 | 11.78 |
| — | +2.5% | -0.7% | -21.8% | +10.3% | +7.5% | +31.2% | +83.5% | +7.5% | -8.9% | -3.6% | -21.4% | -8.0% | |
| EV / EBITDA | 17.16 | 12.69 | 16.31 | 18.72 | 15.98 | 16.84 | 17.33 | 18.74 | 15.27 | 15.36 | 14.29 | 13.39 | 14.08 |
| — | -24.6% | -5.9% | -0.1% | +4.6% | +9.7% | +21.3% | +39.9% | +8.5% | +15.6% | -10.3% | -11.2% | -36.8% | |
| EV / EBIT | 24.55 | 17.80 | 23.15 | 26.40 | 21.59 | 23.93 | 18.81 | 28.47 | 20.80 | 21.57 | 19.25 | 19.33 | 15.99 |
| — | -25.6% | +23.1% | -7.3% | +3.8% | +11.0% | -2.3% | +47.3% | +30.1% | +20.8% | -69.6% | -3.2% | -47.1% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
National Health Investors, Inc.'s operating margin was 45.2% in Q1 2026, down 1.9 pp QoQ and down 8.4 pp YoY. This marks the 4th consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 48.8% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 67.8% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.7% | 31.1% | 33.6% | 97.1% | 96.8% | 96.8% | 96.7% | 96.6% | 96.7% | 96.6% | 96.5% | 96.4% | 95.9% |
| — | -67.8% | -65.3% | +0.5% | +0.1% | +0.1% | +0.2% | +0.3% | +0.9% | -0.2% | -0.3% | -0.6% | -0.5% | |
| Operating Margin | 51.5% | 45.2% | 47.2% | 49.1% | 53.7% | 53.6% | 50.0% | 56.1% | 57.9% | 55.5% | 56.3% | 56.3% | 54.6% |
| — | -15.6% | -5.8% | -12.5% | -7.2% | -3.5% | -11.1% | -0.5% | +6.0% | -1.4% | +10.6% | +2.1% | +29.5% | |
| Net Margin | 37.6% | 34.6% | 35.8% | 36.6% | 40.8% | 38.3% | 50.4% | 34.4% | 41.5% | 38.0% | 40.3% | 36.6% | 51.1% |
| — | -9.5% | -29.0% | +6.3% | -1.7% | +0.8% | +25.0% | -6.1% | -18.8% | -9.3% | +1429.7% | -18.9% | +41.2% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.7% | 2.6% | 2.5% | 2.2% | 2.5% | 2.4% | 3.3% | 2.3% | 2.8% | 2.4% | 2.5% | 2.3% | 3.1% |
| — | +8.5% | -23.5% | -3.5% | -9.7% | -0.8% | +31.0% | -0.4% | -9.7% | -9.0% | +1661.7% | -9.3% | +106.5% | |
| ROA | 5.3% | 1.4% | 1.4% | 1.2% | 1.4% | 1.3% | 1.7% | 1.2% | 1.4% | 1.2% | 1.3% | 1.2% | 1.6% |
| — | +11.4% | -18.4% | +5.5% | -5.1% | +1.6% | +32.6% | -1.5% | -10.0% | -8.9% | +1629.5% | -13.2% | +96.6% | |
| ROIC | 5.6% | 1.9% | 1.4% | 1.3% | 1.4% | 1.4% | 1.3% | 1.5% | 1.5% | 1.4% | 1.4% | 1.4% | 1.3% |
| — | +32.9% | +9.6% | -12.1% | -8.5% | -0.4% | -5.7% | +4.4% | +17.5% | -0.7% | +25.3% | +8.8% | +79.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 1965.8% YoY to 20.02x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.76 | — | 0.76 | 0.74 | 0.75 | 0.87 | 0.83 | 0.91 | 0.90 | 0.90 | 0.89 | 0.89 | 0.88 |
| — | — | -8.7% | -18.8% | -16.9% | -2.7% | -7.1% | +1.9% | +2.2% | -1.5% | +0.1% | +6.3% | +12.5% | |
| Debt / EBITDA | 4.18 | — | 16.03 | 17.25 | 16.31 | 18.84 | 18.61 | 17.68 | 17.05 | 18.15 | 18.35 | 18.27 | 18.84 |
| — | — | -13.9% | -2.4% | -4.3% | +3.8% | +1.4% | -3.2% | -9.5% | -1.2% | -14.8% | -2.3% | -26.6% | |
| Current Ratio | 2.48 | 20.02 | 2.48 | 2.09 | 0.82 | 0.97 | 0.96 | 0.90 | 1.13 | 1.19 | 1.16 | 1.05 | 1.08 |
| — | +1965.8% | +159.1% | +131.3% | -28.0% | -18.3% | -17.2% | -13.9% | +5.1% | +192.3% | -66.2% | -79.9% | -80.4% | |
| Quick Ratio | 2.48 | 20.02 | 2.48 | 2.09 | 0.82 | 0.97 | 0.96 | 0.90 | 1.13 | 1.19 | 1.16 | 1.05 | 1.08 |
| — | +1965.8% | +159.1% | +131.3% | -28.0% | -18.3% | -17.2% | -13.9% | +5.1% | +192.3% | -66.2% | -79.9% | -80.4% | |
| Interest Coverage | 3.45 | 3.64 | 3.83 | — | 3.61 | 3.29 | 4.05 | 2.83 | 3.50 | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying NHI stock.
National Health Investors, Inc.'s current P/E is 24.9x. The average P/E over the last 4 quarters is 24.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
National Health Investors, Inc.'s current operating margin is 51.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking National Health Investors, Inc.'s business trajectory between earnings reports.